SI1104289T1 - New oral formulation for 5-ht4 agonists or antagonists - Google Patents

New oral formulation for 5-ht4 agonists or antagonists

Info

Publication number
SI1104289T1
SI1104289T1 SI9930892T SI9930892T SI1104289T1 SI 1104289 T1 SI1104289 T1 SI 1104289T1 SI 9930892 T SI9930892 T SI 9930892T SI 9930892 T SI9930892 T SI 9930892T SI 1104289 T1 SI1104289 T1 SI 1104289T1
Authority
SI
Slovenia
Prior art keywords
agonists
antagonists
oral formulation
new oral
new
Prior art date
Application number
SI9930892T
Other languages
Slovenian (sl)
Inventor
Bruijn Karel De
Guenter Engel
Hans-Juergen Pfannkuche
Michael Thewissen
Christian Vitzling
Othmar Zueger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en
Priority claimed from GBGB9823477.6A external-priority patent/GB9823477D0/en
Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en
Priority claimed from GBGB9911059.5A external-priority patent/GB9911059D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/EP1999/006083 external-priority patent/WO2000010526A2/en
Publication of SI1104289T1 publication Critical patent/SI1104289T1/en

Links

SI9930892T 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists SI1104289T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9818340.3A GB9818340D0 (en) 1998-08-21 1998-08-21 Organic compounds
GBGB9823477.6A GB9823477D0 (en) 1998-10-27 1998-10-27 Organic compounds
GBGB9910320.2A GB9910320D0 (en) 1999-05-05 1999-05-05 Organic compounds
GBGB9911059.5A GB9911059D0 (en) 1999-05-12 1999-05-12 Organic compounds
PCT/EP1999/006083 WO2000010526A2 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists
EP99942892A EP1104289B1 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists

Publications (1)

Publication Number Publication Date
SI1104289T1 true SI1104289T1 (en) 2006-08-31

Family

ID=36951103

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930892T SI1104289T1 (en) 1998-08-21 1999-08-19 New oral formulation for 5-ht4 agonists or antagonists

Country Status (1)

Country Link
SI (1) SI1104289T1 (en)

Similar Documents

Publication Publication Date Title
HUP0201545A2 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
CZ20011556A3 (en) Pyrazolopyridine derivatives
AU4698299A (en) 5-HT7 receptor antagonists
HK1041224A1 (en) New pharmaceutical formulation
AU1772300A (en) Glucagon antagonists/inverse agonists
EP1072253A4 (en) Oral compositions
HUP9900183A3 (en) Oral fast-dissolving pharmaceutical compositions for dopamine agonists
EP1016400A4 (en) Composition for external use
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
PL346247A1 (en) Muscarinic agonists and antagonists
GB9809450D0 (en) Jitter measurement
HK1034079A1 (en) Tetrahydroquinoline derivatives as glycine antagonists
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
AU4980999A (en) A3 adenosine receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
IL138919A0 (en) Use of nmda antagonists for treatment of irritable bowel syndrome
GB9817650D0 (en) Oral formulation
HUP0103113A3 (en) New pharmaceutical compositions uses for nos inhibitors
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
SI1104289T1 (en) New oral formulation for 5-ht4 agonists or antagonists
PL344872A1 (en) Novel formulation containing paroxetine
HU9902674D0 (en) Estrogen agonists/antagonists
IL139594A0 (en) Novel formulation containing paroxetine
GB9814737D0 (en) Fibrinogen receptor antagonists
SI1073431T1 (en) Use of nmda antagonists for treatment of irritable bowel syndrome